Clinical Laserthermia Systems AB Class B (LS60) AI Stock Analysis

Clinical Laserthermia Systems AB Class B

(Frankfurt:LS60)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Debt-free balance sheetA debt-free capital structure materially reduces refinancing and interest risks, giving management flexibility to prioritize commercialization or R&D. Over months this improves solvency and lowers fixed financing costs, providing runway to execute a turnaround without near-term debt obligations.

Negative Factors

Declining revenue and negative marginsSustained revenue decline and a shift to negative gross margins indicate persistent under-absorption of fixed costs, pricing or mix pressure, and weak demand. These dynamics make achieving sustainable profitability difficult without durable volume recovery or structural cost reductions.

Clinical Laserthermia Systems AB Class B (LS60) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 7.79M
Dividend Yield: ―
Average Volume (3M): 2,000
Price to Earnings (P/E): -1.3
Beta (1Y): 0.06
Revenue Growth: -45.99%
EPS Growth: 41.88%
Country: Germany
Employees: 13
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Specialties

Clinical Laserthermia Systems AB Class B Business Overview & Revenue Model

Company Description

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The...

Clinical Laserthermia Systems AB Class B Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:LS60 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:RAY.B	67Neutral	SEK 6.95B	32.66	22.81%	1.97%	1.42%	10.40%
SE:CRAD.B	64Neutral	SEK 783.39M	16.48	13.23%	0.43%	-8.76%	103.87%
SE:PAX	57Neutral	SEK 1.54B	-303.85	-1.22%	―	34.05%	-144.96%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:SPAGO	43Neutral	SEK 32.09M	-0.85	-106.23%	―	-97.37%	25.28%
SE:SPEC	40Underperform	SEK 20.68M	-0.12	-57.15%	―	―	16.02%

* Healthcare Sector Average

Performance Comparison

DE:LS60 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:LS60	Clinical Laserthermia Systems AB Class B	0.11	-0.53	-82.70%
SE:PAX	Paxman AB	66.30	-1.10	-1.63%
SE:RAY.B	RaySearch Laboratories AB Class B	202.80	-16.56	-7.55%
SE:SPEC	SpectraCure AB	0.01	-0.13	-90.21%
SE:CRAD.B	C-Rad AB Class B	23.20	-9.80	-29.69%
SE:SPAGO	Spago Nanomedical AB	0.04	-0.11	-72.79%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Clinical Laserthermia Systems AB Class B AI Stock Analysis